GlaxoSmithKline PLC Director/PDMR Shareholding (3201D)
26 April 2017 - 2:24AM
UK Regulatory
TIDMGSK
RNS Number : 3201D
GlaxoSmithKline PLC
25 April 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================
a) Name Mr B McNamara
=== ========================= ========================================
b) Position/status CEO, Consumer Healthcare
=== ========================= ========================================
c) Initial notification/ Initial notification
amendment
=== ========================= ========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================
a) Name GlaxoSmithKline plc
=== ========================= ========================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ========================= ========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 13 April 2017 on shares
held in the Deferred Annual Bonus Plan
Post-Tax - matching award.
=== ========================= ========================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$41.1461 28.716
--------- ----------
=== ========================= ========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ========================================
e) Date of the transaction 2017-04-25
=== ========================= ========================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ========================= ========================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHQELFLDZFFBBQ
(END) Dow Jones Newswires
April 25, 2017 12:24 ET (16:24 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024